$2.17
3.83% yesterday
Nasdaq, Nov 25, 09:49 pm CET
ISIN
US52886N4060
Symbol
LEXX

Lexaria Bioscience Corp Target price 2024 - Analyst rating & recommendation

Lexaria Bioscience Corp Classifications & Recommendation:

Buy
100%

Lexaria Bioscience Corp Price Target

Target Price $11.00
Price $2.15
Potential
Number of Estimates 2
2 Analysts have issued a price target Lexaria Bioscience Corp 2025 . The average Lexaria Bioscience Corp target price is $11.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 2 Analysts recommend Lexaria Bioscience Corp to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Lexaria Bioscience Corp stock has an average upside potential 2025 of . Most analysts recommend the Lexaria Bioscience Corp stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Aug '23 2024
Estimates
Revenue Million $ 0.23 0.50
11.54% 117.39%
Net Margin -6,942.65% -1,391.28%
7.92% 79.96%

1 Analyst has issued a sales forecast Lexaria Bioscience Corp 2024 . The average Lexaria Bioscience Corp sales estimate is

$500k
Unlock
. This is
47.06% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$500k 47.06%
Unlock
, the lowest is
$500k 47.06%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $230k 11.54%
2024
$500k 117.39%
Unlock
2025
$600k 20.00%
Unlock

1 Analyst has issued a net profit forecast Lexaria Bioscience Corp 2024 . The average Lexaria Bioscience Corp net profit estimate is

$-7.0m
Unlock
. This is
61.04% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-7.0m 61.04%
Unlock
, the lowest is
$-7.0m 61.04%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-16.0m 18.55%
2024
$-7.0m 56.41%
Unlock
2025
$-5.7m 18.25%
Unlock

Net Margin

2023 -6,942.65% 7.92%
2024
-1,391.28% 79.96%
Unlock
2025
-948.60% 31.82%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Aug '23 2024
Estimates
Earnings Per Share $ -1.01 -0.44
18.55% 56.44%
P/E negative
EV/Sales 64.88

1 Analysts have issued a Lexaria Bioscience Corp forecast for earnings per share. The average Lexaria Bioscience Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.44
Unlock
. This is
61.06% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.44 61.06%
Unlock
, the lowest is
$-0.44 61.06%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.01 18.55%
2024
$-0.44 56.44%
Unlock
2025
$-0.36 18.18%
Unlock

P/E ratio

Current -1.91 64.66%
2024
-5.36 180.63%
Unlock
2025
-5.97 11.38%
Unlock

Based on analysts' sales estimates for 2024, the Lexaria Bioscience Corp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

64.88
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
82.38
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 84.62 192.10%
2024
64.88 23.33%
Unlock
2025
47.95 26.09%
Unlock

P/S ratio

Current 110.35 178.75%
2024
82.38 25.35%
Unlock
2025
62.53 24.09%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today